Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Yimoufeng Biotechnology
Chengdu, Sichuan, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Chengdu Yimoufeng Biotechnology is a Chinese biopharmaceutical company focused on the development of innovative targeted protein degradation (TPD) therapies. Established in 2021, the company utilizes its proprietary molecular glue and PROTAC platforms to address previously "undruggable" targets in oncology and other therapeutic areas. Its pipeline includes small molecule degraders targeting GSPT1 and CK1α, aimed at treating solid tumors and hematological cancers. Headquartered in the Chengdu High-tech Zone, Yimoufeng is part of the growing ecosystem of precision medicine startups in Western China, leveraging advanced screening technologies to discover novel E3 ligase ligands.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeMolecular glue therapyProteolysis-targeting chimera therapy
- Industry
- Biotech
Beyond the preview
Go deeper on Chengdu Yimoufeng Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chengdu Yimoufeng Biotechnology.